ArticleEmerging microbes & infections2019
Molecular surveillance of antimicrobial resistance and transmission pattern of
Abstract read
In one paragraph
Article in Emerging microbes & infections, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Drug Resistance (Dapsone, Rifampicin, Ofloxacin) and Resistance-Related Gene Mutation Features in Leprosy Patients: A Systematic Review and Meta-Analysis.International journal of molecular sciences · 2022Pooled it
- Genotypic investigation of Mycobacterium leprae in patients with relapsing leprosy in Mato Grosso, Brazil.Medical microbiology and immunology · 2025Article
- A Review of the Efficacy, Safety, and Feasibility of Rifamycin-Based Post-Exposure Chemoprophylaxis for Leprosy.Tropical medicine and infectious disease · 2025Review
- Computational investigation of the global prevalence of multidrug resistantJournal of clinical tuberculosis and other mycobacterial diseases · 2024Article
- High-risk spatiotemporal patterns of leprosy in the southeastern region of Yunnan province from 2010 to 2022: an analysis at the township level.BMC public health · 2024Article
- Antimicrobial Resistance Surveillance: Data Harmonisation and Data Selection within Secondary Data Use.Antibiotics (Basel, Switzerland) · 2024Article
- A Bibliometric Analysis of Leprosy during 2000-2021 from Web of Science Database.International journal of environmental research and public health · 2022Article
- Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan.Antimicrobial agents and chemotherapy · 2022Article
- Utility of Multi-target Nested PCR and ELISPOT Assays for the Detection of Paucibacillary Leprosy: A Possible Conclusion of Clinical Laboratory Misdiagnosis.Frontiers in cellular and infection microbiology · 2022Article
- Molecular Surveillance of Antimicrobial Resistance ofInfection and drug resistance · 2022Article
- Reverse vaccinology and subtractive genomics approaches for identifying common therapeutics againstThe journal of venomous animals and toxins including tropical diseases · 2021Article
- Relapse in leprosy and drug resistance assessment in a tertiary hospital of the state of Espírito Santo, Brazil.Revista da Sociedade Brasileira de Medicina Tropical · 2021Observational
- Drug Resistance inIndian dermatology online journalArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
28 authors.
Santosh ChokkakulaInstitute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College , Nanjing , China.ORCID https://orcid.org/0000-0002-1961-4454
Zhiming ChenInstitute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College , Nanjing , China.ORCID https://orcid.org/0000-0001-5794-8968
Le WangInstitute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College , Nanjing , China.ORCID https://orcid.org/0000-0002-9673-3879
Haiqin JiangInstitute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College , Nanjing , China.ORCID https://orcid.org/0000-0002-4924-0465
Yanqing ChenInstitute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College , Nanjing , China.ORCID https://orcid.org/0000-0003-3092-1823
Ying ShiInstitute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College , Nanjing , China.ORCID https://orcid.org/0000-0002-0301-6791
Wenyue ZhangInstitute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College , Nanjing , China.ORCID https://orcid.org/0000-0001-7054-8037
Wei GaoInstitute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College , Nanjing , China.ORCID https://orcid.org/0000-0002-4246-8440
Jun YangYunnan Provincial CDC , Kunming , China.ORCID https://orcid.org/0000-0003-2965-2080
Jinlan LiGuizhou Provincial CDC , Guiyang , China.ORCID https://orcid.org/0000-0002-0376-938X
Xiong LiYunnan Provincial CDC , Kunming , China.ORCID https://orcid.org/0000-0001-9374-9456
Tiejun ShuiYunnan Provincial CDC , Kunming , China.ORCID https://orcid.org/0000-0002-2224-0545
Jun HeYunnan Provincial CDC , Kunming , China.ORCID https://orcid.org/0000-0002-5188-0218
Limei ShenGuizhou Provincial CDC , Guiyang , China.ORCID https://orcid.org/0000-0002-7449-423X
Jie LiuGuizhou Provincial CDC , Guiyang , China.ORCID https://orcid.org/0000-0001-9999-7274
De WangGuizhou Provincial CDC , Guiyang , China.ORCID https://orcid.org/0000-0002-3737-6621
Hao WangSichuan Provincial People's Hospital , Chengdu , China.ORCID https://orcid.org/0000-0002-1045-4642
Huan ChenHunan Provincial CDC , Changsha , China.ORCID https://orcid.org/0000-0001-9447-5151
Yanfei KuangHunan Provincial CDC , Changsha , China.ORCID https://orcid.org/0000-0003-4988-329X
Bin LiHunan Provincial CDC , Changsha , China.ORCID https://orcid.org/0000-0001-9389-7539
Ziyi ChenSuzhou Institute of Systems Medicine , Suzhou , China.ORCID https://orcid.org/0000-0001-9870-4361
Aiping WuSuzhou Institute of Systems Medicine , Suzhou , China.ORCID https://orcid.org/0000-0002-2960-9341
Meiwen YuInstitute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College , Nanjing , China.ORCID https://orcid.org/0000-0001-8000-6987
Liangbin YanInstitute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College , Nanjing , China.ORCID https://orcid.org/0000-0001-8169-9922
Naveen Chandra SuryadevaraVanderbilt University Medical Centre , Nashville , TN , USA.ORCID https://orcid.org/0000-0003-2571-1290
Varalakshmi VissaInstitute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College , Nanjing , China.ORCID https://orcid.org/0000-0002-8994-3819
Weida LiuInstitute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College , Nanjing , China.ORCID https://orcid.org/0000-0003-1936-3736
Hongsheng WangInstitute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College , Nanjing , China.ORCID https://orcid.org/0000-0001-5725-5053
Funding
No grant is acknowledged in the PubMed record.
Abstract
Reports on antimicrobial resistance (AMR) of
Indexed as
Drug Resistance, BacterialAdolescentAdultAgedAged, 80 and overBacterial ProteinsChinaFemaleHumansLeprostatic AgentsLeprosyMaleMicrobial Sensitivity TestsMiddle AgedMutationMycobacterium lepraeBacterial ProteinsLeprostatic Agentsantimicrobial resistancebacteriological indexgenotypingtransmission
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.